News
Announcement Concerning Operational Suspension of Ofuna Plant due to Portfolio Transformation —Consolidation of manufacturing bases in Toyokalon business and withdrawal from Y Film and Caralyan business—
Announcement of Participation in the Taskforce on Nature-Related Financial Disclosures (TNFD) Forum
Announcement of Obtaining the Approval for the Use of Ebola Virus Antigen Rapid Diagnostic Kit “QuickNaviTM-Ebola” in the Democratic Republic of the Congo
Price Revision for Denka Chloroprene
IR Information
FY2024 First Quarter Financial Results Presentation Summary of Q&A Session
FY2024 First Quarter Financial Results Presentation Materials
FY2024 First Quarter Summary of Consolidated Financial Statements
This website uses cookies to ensure that you use this website comfortably. If you continue to browse this website, you will agree to the use of our cookies.